Cellectar Biosciences Inc Sustainability Reports
Cellectar Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company utilizes its proprietary phospholipid drug conjugate delivery platform to develop targeted cancer therapies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493000NFZCRG7BYQV93
FIGI: BBG001SNWCK2
4 reports from 2013 to 2024
